Valerie Jones
Family · Lees Summit, MONPI 1831462167
Payments from drug & device makers
Across 188 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$297
- Lilly USA, LLC$270
- AstraZeneca$228
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$126
- Amgen$106
- plus $858 from 22 others
What the payments were for
- Food & beverage$2,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $1,065 |
| Novo Nordisk | 17 | $297 |
| Lilly USA, LLC | 15 | $270 |
| AstraZeneca | 15 | $228 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $126 |
| Amgen | 7 | $106 |
| Exact Sciences | 5 | $83 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $75 |
| Merck | 5 | $73 |
| Pfizer | 4 | $72 |
| Astellas Pharma US Inc | 4 | $65 |
| Organon | 3 | $56 |
| Boston Scientific | 1 | $54 |
| Abbott | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Exeltis, USA Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Shield Therapeutics Inc | 1 | $26 |
| Johnson & Johnson | 2 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Scynexis, Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Axonics, Inc. | 1 | $14 |
| GSK | 1 | $13 |
How this compares
$2,949 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 112 | $1,604 |
| Gabapentin | 15 | $1,019 |
| Losartan Potassium | 77 | $725 |
| Atorvastatin Calcium | 69 | $654 |
| Rosuvastatin Calcium | 83 | $558 |
| Fluticasone Propionate | 29 | $550 |
| Omeprazole | 34 | $527 |
| Famotidine | 27 | $527 |
| Pravastatin Sodium | 32 | $508 |
| Potassium Chloride | 22 | $474 |
| Hydroxyzine Hcl | 18 | $351 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $337 |
| Simvastatin | 44 | $330 |
| Lisinopril | 83 | $291 |
| Metformin Hcl | 61 | $270 |
Paid to pharmacies, not to this prescriber.
Other family in Lees Summit
- Tamera WolfLees Summit$215K
- Crystal DavisonLees Summit$16K
- Christine HuntLees Summit$12K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.